COVID-19 and Multiorgan Response

• Published in: Current problems in cardiology Vol. 45; no. 8; p. 100618
• Main Authors: Zaim, Sevim, Chong, Jun Heng, Sankaranarayanan, Vissagan, Harky, Amer
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-08-2020; Mosby-Year Book
• Subjects: Angiotensin-Converting Enzyme 2; Betacoronavirus - physiology; Cardiovascular Diseases - epidemiology; Comorbidity; Coronavirus Infections - complications; Coronavirus Infections - epidemiology; Coronavirus Infections - immunology; COVID-19; Humans; Multiple Organ Failure - etiology; Multiple Organ Failure - immunology; Pandemics; Peptidyl-Dipeptidase A - metabolism; Pneumonia, Viral - complications; Pneumonia, Viral - epidemiology; Pneumonia, Viral - immunology; Risk Factors; SARS-CoV-2
• ISSN: 0146-2806; 1535-6280
• DOI: 10.1016/j.cpcardiol.2020.100618

Since the outbreak and rapid spread of COVID-19 starting late December 2019, it has been apparent that disease prognosis has largely been influenced by multiorgan involvement. Comorbidities such as cardiovascular diseases have been the most common risk factors for severity and mortality. The hyperinflammatory response of the body, coupled with the plausible direct effects of severe acute respiratory syndrome on body-wide organs via angiotensin-converting enzyme 2, has been associated with complications of the disease. Acute respiratory distress syndrome, heart failure, renal failure, liver damage, shock, and multiorgan failure have precipitated death. Acknowledging the comorbidities and potential organ injuries throughout the course of COVID-19 is therefore crucial in the clinical management of patients. This paper aims to add onto the ever-emerging landscape of medical knowledge on COVID-19, encapsulating its multiorgan impact.